COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.

FP Trending July 08, 2020 14:06:34 IST
COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

Several pharmaceutical companies across India are currently working towards potential vaccines to prevent coronavirus disease (COVID-19). Five of these candidates have entered the early stages of human trials. As per a report by The Hindu, the Government of India is now preparing a document for these companies and institutions as guideline for COVID-19 vaccines.

The report quotes Secretary in the Department of Biotechnology Dr Renu Swarup as saying that there is likely to be a guidance document for COVID-19 vaccines in a couple of days, issued by the Central Drug Standards and Control Organisation.

"The guidance document outlines how to maintain rigour while also fast-tracking the process,” Swarup told the daily, adding that trials underway in India were "adaptive".

She added that no process in vaccine development trials would be skipped, but regulators may be given approvals to carry out multiple phases of trials parallelly.

COVID19 vaccine in India Government to set guidance document for trials of vaccines treatment

Image credit; U.S. Navy photo by Chief Petty Officer Anthony Sisti

Currently, there are five promising candidate vaccines from India including Covaxin, from Bharat Biotech, and from Zydus Cadilla which have received clearance by the Drug Controller General of India for early human trials.

As per a report by NDTV, the government on Sunday gave approval for human clinical trials for two made-in-India COVID-19 vaccine candidates COVAXIN and ZyCov-D. Both have got a nod for phase two and phase three trials.

A letter by the Ministry of Science and Technology said that there were more than 100 vaccine candidates in the world currently, of which 11 were in human trials.

The first two phases of drug trials test for safety, the report said. The third tests the medicine's efficacy. Each phase can take several months, or even years, to be completed.

So far, India has reported more than 7 lakh 44 thousand cases of COVID-19 . The pandemic has claimed the lives of more than 20,600 people in the country till date.

Updated Date:

also read

Coronavirus Updates: Narendra Modi directs officials to work closely with state govts to start oxygen plants at earliest
India

Coronavirus Updates: Narendra Modi directs officials to work closely with state govts to start oxygen plants at earliest

Coronavirus LIVE Updates: The prime minister on Tuesday chaired a high-level meeting to review the COVID-19 situation in the country and asked the officials to ensure rapid upgradation of health infrastructure

Joe Biden sets new COVID-19 vaccination goal, aims to inoculate 70% of US adults by 4 July
World

Joe Biden sets new COVID-19 vaccination goal, aims to inoculate 70% of US adults by 4 July

Already more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine and nearly 105 million are fully vaccinated

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states
India

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states

The Hyderabad-based firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government